Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Defense & Aerospace

Hensoldt Shares Surge as Defense Orders Reach Record Highs

Dieter Jaworski by Dieter Jaworski
October 6, 2025
in Defense & Aerospace, Earnings, Industrial, MDAX & SDAX
0
Hensoldt Stock
0
SHARES
10
VIEWS
Share on FacebookShare on Twitter

The defense technology group Hensoldt is demonstrating remarkable financial performance, posting record figures that underscore its position as a primary beneficiary of increased global military spending. With revenue climbing 21% to reach €2.24 billion, the company has comfortably surpassed its own projections.

Profitability and Shareholder Returns Exceed Forecasts

The company’s profitability metrics are equally compelling. Adjusted EBITDA surged to €405 million, yielding a robust margin of 19.4%, which clearly exceeded internal guidance. An even more powerful indicator of financial health is the 26% increase in free cash flow, which reached €249 million. This solid financial foundation has enabled management to reward shareholders with a significant 25% dividend hike, raising the payout to €0.50 per share.

A Flood of New Contracts Fuels Growth

The most explosive growth, however, is visible in Hensoldt’s order books. The company registered a record order intake of €2.9 billion, a substantial 40% increase compared to the previous year. This translates to a book-to-bill ratio of 1.3x, indicating that new orders are coming in faster than the company can fulfill them.

Should investors sell immediately? Or is it worth buying Hensoldt?

A series of major contracts secured between October and January, valued at over €1.4 billion, are driving this momentum. Key awards include:
* A €350 million contract for the ECRS Mk1 radar system for the Eurofighter jet.
* Significant air defense orders for its TRML-4D radar systems.
* Modernization programs for the German Bundeswehr’s vehicle fleet.

Assessing the Trajectory: Is This Growth Sustainable?

Looking ahead, the outlook remains positive. For 2025, Hensoldt anticipates further expansion, forecasting:
* Revenue in the range of €2.5 to €2.6 billion.
* A book-to-bill ratio of approximately 1.2x.
* An EBITDA margin around 18%.

CEO Oliver Dörre expressed confidence in the sustainability of this growth cycle, stating, “The world continues to be characterized by a multitude of crisis hotspots, and Europe in particular must sustainably expand its defense capabilities.” The company’s strategy appears to be working, with 40% of new orders now originating from European partner nations. The long-term ambition of achieving €5 billion in revenue by 2030 seems increasingly attainable, supported by the current tailwinds and a record-high order backlog of €6.6 billion. This optimistic picture is reflected in the company’s share price, which is trading near its 52-week high, validating early investors who recognized the potential in the defense sector.

Ad

Hensoldt Stock: Buy or Sell?! New Hensoldt Analysis from February 7 delivers the answer:

The latest Hensoldt figures speak for themselves: Urgent action needed for Hensoldt investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from February 7.

Hensoldt: Buy or sell? Read more here...

Tags: Hensoldt
Dieter Jaworski

Dieter Jaworski

About Dieter Jaworski From a numbers-obsessed child to creating his first investment newsletter. Even as a child, Dieter Jaworski's mother couldn't believe how fascinated he was with numbers. This early passion for mathematics and data analysis laid the foundation for a successful career in financial markets and investment analysis.
Areas of Expertise:
  • Quantitative Analysis
  • Financial Newsletter Publishing
  • Data-Driven Investment Strategies
  • Market Pattern Recognition
Dieter's unique approach combines his natural affinity for numbers with decades of market experience, providing investors with data-driven insights and practical investment strategies.

Related Posts

Orthofix Medical Stock
Earnings

Orthofix Medical Strengthens Scientific Foundation for Biologics Portfolio

February 7, 2026
Myers Industries Stock
Analysis

Myers Industries Set to Report Full-Year and Q4 2025 Results

February 7, 2026
OneSpan Stock
Cyber Security

OneSpan Strengthens Mobile Security Arsenal with Strategic Acquisition

February 7, 2026
Next Post
Novo Nordisk Stock

Danish Pharma Giant Novo Nordisk Faces Diverging Analyst Views

DroneShield Stock

DroneShield Shares Maintain Upward Trajectory on Major U.S. Government Contract

Rheinmetall Stock

Is Rheinmetall's Spectacular Rally Nearing Its End?

Recommended

Super Micro Computer Stock

Super Micro Stock Surges Amid AI Infrastructure Boom

4 months ago
Adobe Stock

Adobe’s AI Ambitions Face Investor Skepticism

4 months ago
IBM Stock

Strong IBM Earnings Fail to Impress Market as Key Segment Shows Weakness

4 months ago
Inozyme Pharma Inc Stock

Inozyme Pharma Acquisition Finalized: Strategic Focus Shifts to Clinical Development

5 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Myers Industries Set to Report Full-Year and Q4 2025 Results

OneSpan Strengthens Mobile Security Arsenal with Strategic Acquisition

Riley Exploration Permian Bolsters Board with Industry Veteran Amid Shareholder Activity

Great Lakes Dredge & Dock: A Cash Flow Inflection Point Approaches

Investors Await March Report for Boston Omaha’s Strategic Direction

Universal Insurance Maintains Quarterly Payout Amid Sector Headwinds

Trending

Orthofix Medical Stock
Earnings

Orthofix Medical Strengthens Scientific Foundation for Biologics Portfolio

by Rodolfo Hanigan
February 7, 2026
0

Investor attention turns to Orthofix Medical as the company bolsters the clinical support for its biologics business...

CrossFirst Bankshares Stock

A New Chapter for First Busey as CrossFirst Merger Finalizes

February 7, 2026
Golden Entertainment Stock

Golden Entertainment to Exit Public Markets in Strategic Privatization Deal

February 7, 2026
Myers Industries Stock

Myers Industries Set to Report Full-Year and Q4 2025 Results

February 7, 2026
OneSpan Stock

OneSpan Strengthens Mobile Security Arsenal with Strategic Acquisition

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Orthofix Medical Strengthens Scientific Foundation for Biologics Portfolio
  • A New Chapter for First Busey as CrossFirst Merger Finalizes
  • Golden Entertainment to Exit Public Markets in Strategic Privatization Deal

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com